comparemela.com

Latest Breaking News On - Proshare advisors - Page 12 : comparemela.com

SITE Centers (NYSE:SITC) Given New $16 00 Price Target at Wells Fargo & Company

SITE Centers (NYSE:SITC – Free Report) had its price objective raised by Wells Fargo & Company from $15.50 to $16.00 in a research note released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. SITE Centers Trading Down 0.5 % Shares of SITC stock opened at $14.14 on Tuesday. The […]

Prime Medicine (NYSE:PRME) Shares Gap Down to $6 50

Prime Medicine, Inc. (NYSE:PRME – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $6.50, but opened at $6.27. Prime Medicine shares last traded at $6.12, with a volume of 160,501 shares traded. Wall Street Analysts Forecast Growth Several brokerages recently commented on PRME. Chardan Capital […]

Camden National (NASDAQ:CAC) Lowered to Sell at StockNews com

StockNews.com cut shares of Camden National (NASDAQ:CAC – Free Report) from a hold rating to a sell rating in a research note released on Friday morning. Camden National Stock Performance NASDAQ:CAC opened at $32.32 on Friday. Camden National has a 12-month low of $26.52 and a 12-month high of $39.70. The company has a quick […]

Luminar Technologies, Inc (NASDAQ:LAZR) Receives $4 45 Average PT from Analysts

Shares of Luminar Technologies, Inc. (NASDAQ:LAZR – Get Free Report) have received an average recommendation of “Hold” from the six research firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have issued a buy recommendation on the […]

Analysts Weekly Ratings Changes for Pliant Therapeutics (PLRX)

Several brokerages have updated their recommendations and price targets on shares of Pliant Therapeutics (NASDAQ: PLRX) in the last few weeks: 5/15/2024 – Pliant Therapeutics had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $36.00 price target on the stock. 5/7/2024 – Pliant Therapeutics had its price target lowered by […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.